Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
8.97
+0.25 (2.87%)
Nov 5, 2024, 1:19 PM EST - Market open
Arcutis Biotherapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$14.40
Upside
+60.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +67.22% | Aug 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +100.67% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +100.67% | Jul 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +100.67% | Jul 10, 2024 |
| Needham | Needham | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +100.67% | May 15, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +100.67% | May 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +78.37% | Apr 12, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $6 → $11 | Hold | Maintains | $6 → $11 | +22.63% | Feb 28, 2024 |
| Mizuho | Mizuho | Strong Buy Reiterates $16 → $17 | Strong Buy | Reiterates | $16 → $17 | +89.52% | Feb 28, 2024 |
| Needham | Needham | Strong Buy Maintains $8 → $16 | Strong Buy | Maintains | $8 → $16 | +78.37% | Feb 28, 2024 |
| Mizuho | Mizuho | Strong Buy Reiterates $8 → $16 | Strong Buy | Reiterates | $8 → $16 | +78.37% | Feb 23, 2024 |
| Mizuho | Mizuho | Hold → Strong Buy Upgrades $4 → $8 | Hold → Strong Buy | Upgrades | $4 → $8 | -10.81% | Jan 3, 2024 |
| Mizuho | Mizuho | Hold → Strong Buy Upgrades $4 → $8 | Hold → Strong Buy | Upgrades | $4 → $8 | -10.81% | Jan 2, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $45 → $10 | Buy | Maintains | $45 → $10 | +11.48% | Nov 13, 2023 |
| JonesTrading | JonesTrading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2023 |
| Needham | Needham | Strong Buy Maintains $22 → $8 | Strong Buy | Maintains | $22 → $8 | -10.81% | Nov 6, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.